Our previous studies conducted in MCF7-ptsp53 cells have demonstrated that overexpression of the wild-type (wt) p53 at permissive temperature 321C leads to growth arrest at the G2/M phase of the cell cycle. To identify novel p53-regulated genes that are responsible for the p53-induced G2/M arrest, we conducted cDNA microarray analyses. The array results indicated that the mRNA level of protein regulator of cytokinesis (PRC1) was significantly decreased when the p53 transactivation activity was turned on, suggesting that PRC1 transcription could be downregulated by p53. In this study, we have extensively examined the functional role of p53 in the regulation of PRC1, a cell cycle protein that plays important roles during cytokinesis. We demonstrate that increased expression of the wt p53 either by exogenous transfection or chemical induction results in reduced mRNA and protein expression of PRC1 in HCT116 p53 þ / þ , HCT116 p53 À/À , MCF-7, T47D, and HeLa cells. Importantly, we show that the decreased PRC1 expression is accompanied by the appearance of binucleated cells, indicating the process of cell division after mitosis being inhibited. By isolation and characterization of a 3 kb genomic fragment containing the 5 0 -flanking region and part of exon 1 of PRC1 gene, we demonstrate that p53 directly suppresses PRC1 gene transcription. We further locate the p53-responsive sequence to the proximal promoter region À214 to -163, relative to the transcriptional start site. The in vivo interaction of p53 with PRC1 gene promoter is further demonstrated by chromatin immunoprecipitation assay. Taken together, these new findings suggest that p53 may have important roles in the regulation of cytokinesis through controlling the transcription of PRC1.
Introduction
The protein p53 is the most important tumor suppressor identified to date. The essential roles of p53 as a gatekeeper to maintain mammalian cell homeostasis and to prevent malignant transformation (Levine, 1997) is well indicated by its frequent mutations occurring in the majority of human tumors including breast tumor (Vogelstein and Kinzler, 1992; Harris et al., 1996; Tarapore and Fukasawa, 2000) . The loss of wild-type (wt) p53 is clearly an important event in breast tumorigenesis (Malkin et al., 1990; Hollstein et al., 1991) . However, the exact mechanisms by which loss of p53 normal function leads to cancer formation and progression are not fully understood. In mammalian cells, the correct cell division is controlled by checkpoints at G1/S transition, G2/M transition, and mitosis. Many studies have indicated p53 being an important integral part of these checkpoints (Bargonetti and Manfredi, 2002) . Accumulated p53 in response to DNA damage or through experimental overexpression has been shown to cause growth arrest at G1 (Agami and Bernards, 2000; Wesierska-Gadek and Schmid, 2000; Willers et al., 2000) and/or G2 (Agarwal et al., 1995; Taylor et al., 1999; Taylor and Stark, 2001; Nakamura et al., 2002) or to induce apoptosis (Vousden, 2000; Kokontis et al., 2001) . In some cases, overexpression of the wt p53 induces cellular senescence (Sugrue et al., 1997; Dubrez et al., 2001; Jung et al., 2001) . However, at present, it is not fully understood what factors are involved in the determination of cell fate in response to high cellular levels of p53. Moreover, the p53 downstream target genes mediating different cellular responses to p53 have not been completely characterized.
We have stably transfected a temperature-sensitive (ts) p53 mutant p53Val 135 in MCF-7 breast cancer cells to establish a cell system (MCF7-ptsp53) where the transactivating function of p53 can be turned on or turned off by culturing cells at either permissive temperature 321C or at the nonpermissive temperature 371C (Michalovitz et al., 1990; Milner and Medcalf, 1990; Martinez et al., 1991) . Interestingly, flow cytometric analysis of the DNA content shows that overexpression of the transcriptionally active p53 at 321C arrested the growth of MCF-7 cells by exclusively increasing the percentage of cells in the G2/ M phase without affecting G0/G1 phase or inducing apoptosis (Li et al., 2003) . Thus, this cell line provides us a relatively unique system to characterize p53-initiated molecular events occurring at the G2/M phase. In order to identify novel p53-regulated genes that are responsible for the p53-mediated G2/M arrest, we performed cDNA microarray analyses to compare the gene profiles of MCF7-ptsp53 cells cultured at either 371C or at 321C.
Using the criteria of twofold as a cutoff line, the expressions of 14 genes were shown differentially regulated by wt p53 overexpression but not by nonspecific temperature switch (Li et al., 2003) . Interestingly, none of the p53-regulated genes is related to apoptosis. However, four genes that previously have demonstrated to be involved in G2/M arrest were affected by the overexpression of wt p53 including p21, cdc2, cyclin B2, and PRC1. The former three genes have been demonstrated in a number of studies to be involved in p53-mediated G2 arrest (Dulic et al., 1998; Taylor et al., 1999; Kruse et al., 2000; Manni et al., 2001; Yin et al., 2001) . However, PRC1 is a newly characterized cell cycle protein and its regulation by p53 or by other agents that affect cell cycle have not been reported.
The terminal stage of the cell cycle is cytokinesis. During the process of cytokinesis, cells divide their organelles, cytoplasm, plasma membrane, and other cell contents into two daughter cells (Stright and Field, 2000) . PRC1, a recently characterized mitotic spindleassociated Cdk substrate, has been shown to have an exclusive role in cytokinesis (Jiang et al., 1998; Mollinari et al., 2002) . Microinjection of anti-PRC1 antibodies into HeLa cells blocked cellular cleavage without affecting nuclear division, which resulted in binucleated cells (Jiang et al., 1998) . The essential role of PRC1 in cell cleavage was also demonstrated by using PRC1 small interfering RNA (siRNA) to block its expression (Mollinari et al., 2002) . It was shown that in the absence of the PRC1 protein, cells were able to progress normally in mitosis to metaphase and underwent normal chromatid segregation in anaphase. However, cells lacking PRC1 always showed aberrant anaphase spindle morphology and became increasingly binucleate with time. Further studies demonstrate that PRC1 regulates cytokenesis by stabilizing the midzone microtubule bundle and permitting completion of cell cleavage. The requirement of PRC1 for cell cleavage can also be inferred from its expression pattern. PRC1 expression levels are high during S and G2/M and drop dramatically after cells exit mitosis and enter G1 (Jiang et al., 1998) . However, the factors that control the cell cyclespecific expression of PRC1 are largely unknown.
In this study, we have extensively examined the functional role of p53 in the regulation of PRC1 expression. Through several different lines of investigation, we provide strong evidence to demonstrate that PRC1 gene transcription is negatively regulated by p53. Our new findings suggest that p53 as the gatekeeper to maintain mammalian homeostasis may exert its function to control the final checkpoint for cell division at the stage of cytokinesis by transcriptional suppression of PRC1.
Results

Overexpression of p53 downregulates PRC1 gene expression in MCF-7 cells
To identify specific wt p53-regulated genes, we performed four sets of microarray analysis. First, gene expression profiles of MCF7-ptsp53 grown at 321C and 371C were compared. Second, MCF7-ptsp53 grown at 321C was compared to untransfected parental MCF-7 cells grown at 371C. Third, MCF7-ptsp53 grown at 371C was compared to untransfected parental MCF-7 cells grown at 371C. The last set of experiment was designed to assess the effect of temperature switch (37-321C) on general gene expression of MCF-7 cells, as a negative control for the specific changes induced by p53 overexpression. The array results showed that the PRC1 mRNA level in MCF7-ptsp53 cells cultured at 321C was decreased by 70% as compared to cells cultured at 371C (Figure 1a , bar 1) and was decreased by 78% as compared to MCF-7 cells cultured at 371C (bar 2). On the contrary, the temperature switch had no effect on PRC1 mRNA expressions in MCF-7 cells (bar 4). The data also indicated that overexpression of mutant p53 (ptsp53 Val135 ) did not significantly affect PRC1 mRNA expression, as MCF7-ptsp53 and MCF-7 cells cultured at 371C expressed similar amounts of PRC1 mRNA (bar 3). These results demonstrated an inverse relationship between p53 transcriptional activity and PRC1 expression.
To follow up on this observation, Northern blot analysis was performed to detect the changes of PRC1 mRNA levels after the ptsp53 cells were switched from 37-321C. The results in Figure 1b show that the PRC1 mRNA was downregulated by wt p53 in a timedependent manner. The level of PRC1 mRNA began to drop by 6 h of culturing in the permissive temperature. By 24 h at 321C, only 40% of the mRNA remained, and a residual level of the PRC1 mRNA could be detected after 48 h. Again, the temperature switching had no effect on PRC1 mRNA expression in the parental and the mock-transfected control clone (neo). We further conducted a quantitative real-time PCR assay using cDNAs prepared from mRNAs isolated from different samples. The results confirmed the kinetics of p53-mediated downregulation of PRC1 mRNA expression (Figure 1c) . Examination of PRC1 protein levels in these cells led to corroborated findings in that the PRC1 protein level was decreased to 31% of control at 24 h and further decreased to 15% at 48 h by temperature shift-down (Figure 1d ) only in MCF7-ptsp53 cells but not in parental MCF-7 cells.
Overexpression of p53 downregulates PRC1 gene expression in other cell lines
The above experiments were carried out in MCF-7 breast cancer cell line. To further confirm the correlation between p53 overexpression and downregulation of PRC1 gene expression, different cell systems were used. T47D and HeLa cells were cotransfected with a wt p53 expression vector pBSp53 and pEGFP or mock transfected (pEGFP plus pBS empty vector). Two days post transfection, cells were subjected to cell sorting using green fluorescent protein (GFP) as a marker for transfection. After separation, GFP-positive cells were collected and total cell lysates as well as total RNA were harvested. Figure 2a (middle panel) and Figure 2b confirmed the increased protein levels and the transactivating activities of p53 in pBSp53-transfected cells. Figure 2a also shows that exogenously expressed wt p53 reduced PRC1 protein level by 52% in T47D and by 67% in HeLa cells, as compared to that in untransfected or mock-transfected cells.
Real-time PCR to detect PRC1 mRNA levels in pBSp53 transfected cells confirmed the results of Western blot (Figure 2c ). Together, these results demonstrate that downregulation of PRC1 mRNA and protein expression by p53 are not limited to MCF7-ptsp53 cells. Comparison of the PRC1 mRNA levels by microarray. MCF7-ptsp53 and MCF-7 cells were cultured at 371C or 321C for 4 days, respectively. Total RNA isolated from both cell lines were labeled with either cy3-dCTP or cy5-dCTP according to different experimental designs. The graph illustrates the ratio of PRC1 mRNA expression level in the paired samples. Bar 1, MCF7-ptsp53 at 321C versus MCF7-ptsp53 at 371C; Bar 2, MCF7-ptsp53 at 321C versus MCF-7 at 371C; Bar 3, MCF7-ptsp53 at 371C versus MCF-7 at 371C; Bar 4, MCF-7 at 321C versus MCF-7 at 371C. (b) Northern blot: MCF-7, MCF-7-neo, and MCF7-ptsp53 were seeded at 371C. After switching to 321C, cells were harvested at different times as indicated. Total RNA was isolated and 15 ıg per sample was analysed for PRC1 mRNA by Northern blot. The membrane was stripped and hybridized to a human GAPDH probe. (c) Real-time PCR: The relative amounts of PRC1 mRNA harvested from MCF-7 or ptsp53 cells cultured at 321C for various times were measured by a quantitative real-time RT-PCR assay using a PRC1-specific fluorogenic probe from Gorilla Genomics. The amount of PRC1 mRNA in cells cultured at 371C was defined as 100, and the amount of PRC1 mRNA at different time points was plotted relative to that value. The data shown are derived from three separate experiments. (d) Western blot: MCF7-ptsp53 or MCF-7 seeded at 371C were switched to 321C at the same time and total cell lysates were harvested at different time points as indicated. In all, 50 mg protein/sample was analysed for PRC1 protein expression by Western blot. The membrane was stripped and reprobed with anti-a´-actin for normalizing differences in protein loading In addition to overexpression of the wt p53, we were interested in determining whether PRC1 expression could be repressed in a physiological environment with an elevated level of endogenous p53. To investigate this, we treated HCT116 p53 þ / þ and HCT116 p53 À/À with the therapeutic drugs 5-FU at 50 mg/ml or Dox at 2 mg/ ml for 24 h. We also treated MCF-7, T47D, and HeLa cells with 5-FU at an effective dose of 10 mg/ml, which has been shown to increase cellular p53 protein levels in several cell lines (Chun and Jin, 2003) . Following the treatment, the p53 and PRC1 protein levels were examined by Western blotting. Figure 3a and c (top panel) showed that the therapeutic drugs only effectively induce endogenous p53 expression in HCT116 p53
and MCF-7 cells that have functional p53; whereas p53 was not induced in HCT116 p53
À/À cells which are p53 null, and T47D which does not have functional p53. P53 protein level in HeLa cells was also not induced due to the expression of the human papillomavirus E6 protein, which targets p53 for degradation. The induction of endogenous p53 by 5-FU or Dox considerably repressed PRC1 protein expression in HCT116 p53
þ / þ and MCF-7 cells, whereas the PRC1 expressions in HCT116 p53 
Downregulation of PRC1 gene expression by p53 overexpression results in binucleation
PRC1 is a microtubule binding and bundling protein essential to maintain the mitotic spindle midzone. Mollinari et al. (2002) have shown that complete suppression of PRC1 by siRNA in HeLa cells resulted in about 10% cells becaming binucleated after 24 h treatment of siRNA. We sought to determine whether the decreased PRC1 expression caused by p53 overexpression has similar inhibitory effects on cell division. First, by performing wt p53 immunostaining and DAPI staining, we examined the cell p53 level as well as the nuclei of MCF7-ptsp53 and regular MCF-7 cells that had been cultured at 321C for 2 days. Under this condition, we found that over 95% of the ptsp53 cells cultured at 32 o C overexpressed wt p53 and approximately 3% of these cells had two nuclei per cell ( Figure 4 , top panel). In contrast, we could not find any binucleated cells in MCF-7 cells (image not show). We have tried to detect the cell PRC1 level by immunostaining, but we could not obtain a specific staining by the current PRC1 antibody. Next, we extended this observation to HCT116 p53 À/À cells after transfection of pBSp53 and pEGFP and enrichment of transfected cells by cell sorting. We found that about 95% of the transfected cells overexpressed wt p53 and 2% of these cells became binucleated ( À/À cells were treated with 5-FU (50 mg/ml) or Dox (2 mg/ml) for 24 h. MCF-7, T47D, and HeLa cells were treated with 10 mg/ml of 5-FU for 48 h. Total cell lysate as well as total RNA were isolated from these samples. 
p53 suppresses PRC1 promoter activity
To determine an inhibitory effect of p53 on PRC1 gene transcription, we first isolated a 3 kb genomic fragment of PRC1 gene covering from À2964 to þ 76 relative to the transcription start site. This was accomplished by a PCR reaction using RPCI 11 human genomic clone as a template. The PCR product was subcloned into the pGL3-basic luciferase reporter. The resulting plasmid was named PRC1-3 kb. The ATG translation start codon was excluded from the fragment to ensure the correct translation of luciferase gene product. HCT116 p53
, MCF-7, T47D, and HeLa cells were cotransfected with PRC1-3 kb along with the pRSV-Luc normalizing vector. In all four cell lines, PRC1-3 kb showed the luciferase activities. In MCF-7, the PRC1-3 kb luciferase activity was 20-fold of the promoterless vector pGL3-basic. In HCT116 p53 À/À , T47D, and HeLa cells, the PRC1-3 kb luciferase activities were over 100-fold of pGL3-basic (data not shown). These results indicate that the isolated 3 kb fragment contains the functional PRC1 promoter. The fact that the PRC1 promoter activity was fivefold lower in MCF-7 cells that express functional wt p53 than that in HCT116 p53 À/À , HeLa, and T47D cells implies that the PRC1 promoter activity is subjected to the negative regulation by endogenous p53.
To examine the effect of p53 on PRC1 transcription, we transfected PRC1-3 kb in the presence of different amounts of pBSp53 into HCT116 p53 À/À or T47D cells. At 2 days after transfection, the PRC1 promoter activities in transfected cells were determined. Figure 5a and b show that p53 inhibited PRC1-3 kb promoter activity in a dose-dependent manner in HCT116 p53
À/À and T47D cells. PRC1-3 kb promoter activity was nearly completely suppressed by the highest dose of pBSp53 in both cell lines. In a parallel experiment, p53 reporter vector p53Luc was cotransfected with different amounts of pBSp53 into HCT116 p53
À/À cells. The result in Figure 5c demonstrated the dose-dependent increase of p53 transactivating activity in these transfected cells. We also determined the time-dependent effect of p53 expression on PRC1 promoter activity in T47D cells. PRC1 promoter activity was decreased to 34.1% of control at 16 h and further decreased to 6.1% at 48 h by exogenous expression of p53 (Figure 5d ). At each time point, pBS empty vector was used as a control to pBSp53.
The effects of p53 overexpression on PRC1 promoter activities in MCF-7 and HeLa cells were further examined. In MCF-7, cotransfection of pBSp53 with PRC1-3 kb reduced the luciferase activity by 49% as compared to that of the empty vector-transfected cells. In HeLa cells, 45% reduction in PRC1 promoter activity was observed after cotransfection of PRC1-3 kb with pBSp53 (data not shown).
Localization of the p53-responsive region to the proximal section of the PRC1 promoter To understand how p53 regulates PRC1 transcription, the identification of p53-responsive cis-regulatory elements on PRC1 promoter is of importance. To this end, serial deletions of the 5 0 -flanking region of PRC1-3 kb promoter were made. Figure 6 illustrates the nucleotide sequence spanning the PRC1 proximal promoter region from -281 to þ 76 and a schematic diagram of the deletion constructs. T47D cells were transfected with these truncated constructs individually with pBSp53 or with the empty vector pBS, and assayed for luciferase activities. Figure 7a compared the basal promoter activity of the deletion constructs with the activity of the full promoter construct PRC1-3 kb. These results, summarizing six separate transfections, showed that deletion of the 5 0 -flanking region from 3 kb to À282 did not affect the PRC1 promoter basal activity at all. However, additional deletion of 67 nucleotides drastically reduced the promoter activity by more than 80%. Further deletions to -9 gradually reduced the promoter activity to the baseline. These data demonstrate that the functional regulatory elements controlling the basal transcription of PRC1 gene reside within a 272 bp region between À281 and À10. P53 was able to repress the promoter activities of PRC1-281 and PRC1-214 to the same extent as PRC1-3 kb (Figure 7b ), but it lost responsiveness to the promoter constructs PRC1-163, PRC1-99, and PRC1-9. To confirm the presence of the p53-responsive element within the region of À214 to À163, we made an internal deletion construct (PRC1-281-del) that does not contain the fragment between À216 and À161. The results in Figure 8 show that deletion of this region increased the basal promoter activity (Figure 8a ) but significantly reduced the response to p53-mediated suppression (Figure 8b ). These data provide additional evidence to support the functional role of this region in p53-mediated downregulation of PRC1 transcription. Sequence analysis using MatInspector failed to detect a consensus or a homologous p53-binding site within the whole 272 bp basal promoter region or within the p53-responsive region (À214 to À163). This p53-responsive region, however, does contain a GC-rich sequence (À206 to -199) and a putative NF-kB site (À195 to À181). Thus, site-directed mutagenesis on the promoter construct PRC1-281 was performed to individually mutate the GC-rich stretch (muGC) or the NF-kB site (muNF-kB). The contributions of these À/À cells seeding in 24-well culture plates were cotransfected with p53Luc reporter DNA, pBSp53 (with indicated amount of plasmid), and a normalizing vector pRSV-Luc for 48 h. The normalized p53 reporter luciferase activity in the absence of p53 expression is expressed as 100%. (d) Time-dependent suppression of PRC1 promoter activity by p53 in T47D: T47D cells seeding in 24-well culture plates were cotransfected with PRC1-3 kb reporter DNA, pBSp53 (or pBS vector as control), and normalizing vector pRSVLuc. Cells were harvested at different intervals after transfection. At each time point, the normalized PRC1-3 kb luciferase activity in the pBS empty vector-cotransfected cells is expressed as 100% Figure 6 Nucleotide sequence of the proximal 5 0 -flanking region of PRC1 gene and a diagram of the PRC1 promoter deletion constructs. In (a), the first nucleotide in exon 1 is putatively signed as the transcription start site and is indicated by an arrow. The arrowheads indicate the truncation sites. The defined p53-responsive region is bold and underlined. In (b), PRC1 genomic fragments with different 5' deletions were cloned into pGL3-basic luciferase vector
Regulation of PRC1 by p53 C Li et al sequences to the basal and p53-repressed PRC1 promoter activity were assessed by transfection of the wt and the mutated constructs into T47D cells in the absence or the presence of pBSp53. The upper panel of Figure 9 shows that nucleotide alternation within the GC-rich sequence reduced the basal PRC1 promoter activity by 65% and mutation within the NF-kB site moderately lowered the promoter activity by 37%. However, none of these mutations individually abolished the p53-mediated repression of the promoter activity (Figure 9, lower panel) . These data suggest that the GC-rich region and the NF-kB site are important for the PRC1 promoter basal activity, but they are expendable for the p53-mediated suppression of the PRC1 transcription.
p53 interacts with PRC1 promoter in vivo
To determine whether p53 could interact with the proximal region of the PRC1 promoter in vivo, we performed chromatin immunoprecipitation (ChIP) experiments. The MCF7-ptsp53 cell system was used for this purpose. MCF7-ptsp53 cells cultured at 371C or 321C for 48 h were treated with formaldehyde to generate covalently crosslinked DNA-protein complex within the cells. Crosslinked chromatin was then immunoprecipitated with antibody against p53. Normal rabbit IgG was used as a nonspecific binding control. PCR amplification was then performed on the immunoprecipitated DNA and on the total input DNA. was deleted from PRC1-281) as well as other PRC1 promoter constructs into the T47D cells. PRSV-Luc was cotransfected as a normalizing plasmid. Cell lysates were harvested 48 h after transfection and the luciferase activities were measured using the dual luciferase assay kit. The normalized PRC1-281 promoter activity is defined as 100%, other promoter constructs' activities are presented as percentage of that value. (b) p53-mediated suppression. T47D cells were transfected with different PRC1 promoter constructs and pRSV-Luc with pBSp53 or with pBS empty vector. At48 h post transfection, cells were harvested and the luciferase activities were analysed. The normalized luciferase activity of each construct in the pBSp53-transfected cells was compared to that of the pBS vector which is expressed as 100% Figure 7 Truncation analyses of PRC1 basal promoter activity and p53-mediated suppression of the PRC1 promoter activity. (a) Comparison of the PRC1 promoter activities driven by different lengths of the 5 0 -flanking sequences: T47D cells were transfected with different PRC1 promoter deletion constructs along with the pRSV-Luc normalizing vector. Cell lysates were harvested 48 h after transfection and the firefly luciferase activity and the renilla luciferase activity were measured using the dual luciferase assay kit. The data shown are summarized results of six independent transfection assays in which triplicate wells were used in each condition. The PRC1-3 kb promoter activity is defined as 100%, other promoter constructs' activities are presented as percentage of that value. (b) Localization of the p53-responsive region of PRC1 promoter: T47D cells were transfected with different PRC1 promoter constructs and pRSV-Luc with pBSp53 or with pBS empty vector. At 48 h post transfection, cells were harvested and the luciferase activities were analysed. The normalized luciferase activity of each construct in the pBSp53-transfected cells was compared to that of the pBS vector which is expressed as 100%. The data shown are summarized results of four independent transfection assays in which triplicate wells were used in each condition. The different responses to p53 between PRC1-214 and PRC1-163 are statistically significant (Po0.05). In these assays, pGL3-basic vector is included to filter out nonspecific effects of p53 on luciferase activity
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Primers were designed to amplify the region from À281 to þ 76 of the PRC1 gene that contained the full promoter activity as well as the p53-responsive region. Primers to amplify the p53-responsive region within the p21 promoter were used as a positive control (Kaeser and Iggo, 2002) . Figure 10 showed that PRC1 and p21 chromatins were specifically immunoprecipitated with anti-p53 antibody only from MCF7-ptsp53 cells maintained at 321C (Figure 10 , right panel) that express the functional p53 but not from cells cultured at 371C that expressed the mutant p53 ( Figure 10 , left panel). These data clearly indicate the in vivo association of wt p53 with PRC1 gene promoter and provide additional evidence to support the regulatory role of p53 in PRC1 gene transcription.
Discussion
Mammalian cells proceed through the cell division cycle in a strictly ordered fashion. To do so, cells must precisely duplicate their chromosomal DNA during S phase, segregate the sister chromatids to opposite poles of spindle during mitosis, then proceed with the process of cytokinesis that finally leads to daughter cell separation. P53, the cellular gatekeeper for growth and division, is known to play key roles in the checkpoints of G1 to S phase transition and G2 to M phase transition. The p53-mediated G2/M checkpoint is thought to account for the phenotype of genetic instability that is commonly associated with a p53 mutation (Cheng and Loeb, 1993) . In this study, we demonstrate a new function of p53 in cytokinesis through its action as a negative regulator of PRC1, a protein that plays important roles in cytokinesis. Exogenous overexpression of the wt p53 resulted in decreases of PRC1 mRNA and protein levels not only in MCF-7 or T47D breast cancer cells but also in HeLa and the p53 null HCT116 p53 À/À cells, thereby suggesting that the ability of p53 to regulate PRC1 is a general property of this tumor suppressor protein. The decline in PRC1 protein and mRNA expression in responses to elevated endogenous p53 level in HCT116 p53 þ / þ and MCF-7 cells after therapeutic drugs treatment provide additional support to this newly characterized function of p53 (Figure 3) . Although in our studies we did not use mutant constructs of p53 containing different mutations, the microarray experiments comparing MCF7-ptsp53 overexpressing the ts mutant of p53 with the p53 wt MCF-7 revealed similar levels of PRC1 mRNA, thus suggesting that the function of p53 in suppression of PRC1 gene transcription is specific for the wt p53.
Since high levels of PRC1 at the G2/M phase have been shown to be required for HeLa cells to exit mitosis, the suppressed PRC1 expression in MCF7-ptsp53 cells cultured at the 321C likely contributes to the growth arrest of these cells at the G2/M stage of the cell cycle. In HeLa cells, the inhibited expression of PRC1 by siRNA gave rise to binucleated cells, and the percentage of binucleation increased with time. In our studies, we have detected binucleated cells in all four cell lines within 2-3 days after overexpression of the wt p53, either by temperature switching of MCF7-ptsp53 cells, or by transient transfection of pBSp53 into HCT116 p53
, HeLa, and T47D cells. In general, 2-5% of Figure 9 The proximal GC-rich motif and NF-kB site are important for basal PRC1 transcriptional activity but they are not essential for p53-mediated suppression. The effects of p53 on the wt PRC1 promoter construct PRC1-281 and the two mutant constructs were assessed by transient transfection of these plasmids with pBSp53 or with pBS control vector, respectively, into T47D cells. Luciferase reporter assays were conducted as described in Figure 7 . The data (mean7s.d.) were derived from four separate transfection experiments. In the upper panel, the normalized luciferase activity of PRC1-281 is expressed as 100%. In the lower panel, the luciferase activity of each vector in pBS controltransfected cells is expressed as 100% Figure 10 ChIP of PRC1 promoter. MCF7-ptsp53 cells were cultured at 371C or at 321C for 2 days. ChIP was performed with antibody against p53. Normal rabbit IgG was included in the assay as a negative control for nonspecific binding. P53 binding was tested by using PRC1-specific primers; p21 primers were used as a positive control for p53 binding. Bound represents the DNA coimmunoprecipated with antibody, while input represents the starting material before immunoprecipitation Regulation of PRC1 by p53 C Li et al p53-overexpressed cells were shown to become binucleated. This was in sharp contrast with the mocktransfected cells in which binucleated cells were rarely found under the same experimental conditions. In our experimental settings, overexpression of the wt p53 deceased the PRC1 protein levels by 70-80% after 2 days, the incomplete suppression of PRC1 expression may explain the relatively low percentage of binucleated cells. Alternatively, some other cellular genes that are not downregulated by p53 may also need to be inhibited in order to completely stop cell division. Owing to the limitations of transient transfection, we could not examine this binucleation phenomenon over a longer period of time in HCT116p53 À/À , HeLa, or T47D cells. In MCF7-ptsp53 cells, soon after temperature shift down, cells became growth arrested with little proliferative activity. Thus, we could not observe increased population of binucleated cells even after 1 week of culturing at the permissive temperature.
In an attempt to further characterize the regulatory function of p53 on PRC1, we have made a construct encoding a his-tagged PRC1. Transient transfection of this vector into cells generated the typical phenotype as previously observed in HeLa cells (Mollinari et al., 2002) . Revealed by immunostaining with anti-His antibody, PRC1 formed brightly stained fiber rings surrounding the nucleus (data not shown). We were interested in determining whether enforced expression of PRC1 could override the p53-induced G2/M arrest by establishing stable PRC1 expression clones of MCF7-ptsp53. However after transfection of His-PRC1 into cells, the transfected cells grew very slow and we could not isolate positive clones after antibiotic selection. It is possible that overexpression of PRC1 has a negative impact on cell growth. P53 exerts its functions by engaging in complexes with other proteins (Espinosa and Emerson, 2001) or by acting as a transcriptional activator or repressor (Levine, 1997) . As a transcription activator, p53 binds DNA in a sequence-specific manner (Vogelstein and Kinzler, 1992; Levine, 1997) . However, as a transcription repressor, different DNA motifs have been shown to be involved in p53-mediated suppression (Seto et al., 1992) . Compared to the gene activation through a direct binding of p53 to its recognition sequence, the mechanisms of transcriptional suppression by p53 are much more complex and are less clearly defined (Harris et al., 1996; Manni et al., 2001) . In this study, we have isolated PRC1 promoter and demonstrate that p53 suppress PRC1 promoter activity in dose-and time-dependent manners, thus proving that p53 suppresses PRC1 expression by modulating its transcription.
Our deletion analyses have clearly defined the region from À281 to À9 of the 5 0 -flanking sequence being the functional region of the PRC1 promoter. Interestingly within this 272 bp section, almost 80% of the transcriptional activity is driven by regulatory elements located with a 70 bp section (À281 to À214). Several transcription factor-binding sequences are clustered within this region including a muscle initiation sequence, a Sp1-binding site, a CAT box, and a Ap1/CREB site. The contribution of these regulatory sequences in the control of PRC1 transcription during cell cycle awaits further investigation.
With regard to p53, we have searched for the regulatory sequences responsible for p53 suppression. Our transient transfection results point to the sequences between À214 and À163 as the p53-responsive region. This region does not contain a classical p53-binding sequence nor the newly identified p53-repressive element in MAD1 promoter (Chun and Jin, 2003) . As other studies have demonstrated that p53 could inhibit gene transcription through interruption of positive transcription factors such as Sp1 to bind its recognition sequence, and this p53-responsive region contains a classical Sp1-binding motif and a putative NF-kB-binding site, we mutated both sites to examine their roles in the basal transcription and in the p53-mediated suppression of PRC1 transcription. While mutations at either site lowered the basal PRC1 promoter activity, neither mutation abolished the p53 suppression ( Figure 9 ). Collectively, these results suggest that p53 may repress PRC1 transcription through distinct mechanisms.
In order to assure the functional role of p53 in PRC1 transcription, ChIP assays were performed. As shown in Figure 10 , p53 antibody could only precipitate the PRC1 chromatin in MCF7-ptsp53 cells maintained at 321C that express the functional p53 but not in cells cultured at 371C that express the mutant p53. Similar results were found with p21 chromatin, which has a well-defined p53-responsive element. ChIP assay further confirmed that PRC1 is a p53-targeted gene and p53 regulates PRC1 expression at a transcriptional level.
We have attempted to detect the binding of p53 to the defined p53-responsive region of PRC1 promoter by conducting gel shift assay using recombinant p53 protein. While p53 could bind strongly to a wt p53 consensus sequence, we could not detect p53 binding to the oligonucleotide probe containing the PRC1 p53-responsive region (À216 to À163) (data not shown). These preliminary results suggest that the interaction of p53 with PRC1 promoter may occur in the presence of other cofactors. Studies to fine map the p53-responsive sequences and to identify the cofactors that are involved in the p53-mediated suppression of PRC1 transcription are under further investigation in our laboratory.
In conclusion, we have identified a new p53 target gene PRC1 whose transcription is subject to the negative regulation of p53. Regarding the physiological significance of PRC1 repression by p53, we hypothesize that in addition to G1/S and G2/M checkpoints, p53 as the most important tumor suppressor that may provide a final checkpoint control for cell division at the stage of cytokinesis by repressing the transcription of the PRC1 gene whose expression is required for cell cleavage at the end of mitosis, thereby preventing premature entry into another round of cell proliferation. Hence, the effects of p53 on blocking cytokinesis may provide additional protection to maintain genomic integrity and to prevent cancer formation in situations of failed G1 or G2 checkpoints.
Materials and methods
Cells and reagents
Human cancer cell lines MCF-7, T47D, and HeLa were obtained from American Type Culture Collection (Manassas, VA, USA). All cell lines were cultured in RPMI-1640 medium supplemented with 10% FBS. Stable MCF7-ptsp53 clone constitutively expressing p53Val 135 mutant was generated in our laboratory and were cultured in RPMI-1640 medium containing 10% FBS and G418 (300 mg/ml) (Li et al., 2003) . The HCT116 human colon adenocarcinoma cells and a derivative with a homozygous disruption of the p53 gene were a generous gift from Dr Bert Vogelstein (Johns Hopkins University School of Medicine, Baltimore, MD, USA) and were grown in MaCoy's 5A medium supplemented with 10% FBS and antibiotics. The rabbit anti-PRC1 serum was a generous gift of Dr Tony Hunter (The Salk Institute).
Microarray analysis
The human cDNA array containing some 40-45 K genes was obtained from the Microarray Core Facility at Stanford University School of Medicine. Detailed procedure for probe labeling and hybridization were as described previously (Li et al., 2003) . Briefly, MCF7-ptsp53 and MCF-7 cells in RPMI-1640 with 10% FBS were cultured at 371C or 321C for 4 days. In all 60 mg of total RNA per sample was used to generate the first-strand cDNA probe in the presence of cy3-dCTP (for MCF7-ptsp53 or MCF-7 at 371C) or cy5-dCTP (for MCF7-ptsp53 or MCF-7 at 321C) in the reaction of RT. Labeled cDNA probes were purified and hybridized to an arrayed slide overnight at 651C. The fluorescent images were captured using a GenePix 4000 scanner (Axon Instruments, Foster city, CA, USA). To analyse the array data, the CLUSTER program was applied to obtain an average-linkage hierarchical clustering and the results were displayed by using the program TREEVIEW (software available at http://genome-www4. stanford.edu/MicroArray/SMD/restech.html). The fluorescent intensities of cy-5 and cy-3 for each target spot were automatically adjusted by the analysing program in a way that the housekeeping genes for each slide became equal. The genes whose expression varied by at least twofold from the median red/green rating were subsequently selected and grouped according to their primary functions defined by GeneCards (http://bioinformatics.weizmann.ac.il/cards/).
RNA isolation and Northern blot analysis
MCF-7, MCF-7-neo, and MCF-7-ptsp53 were seeded in 60 mm dishes in RPMI-1640 media supplemented with 10% FBS at 371C. The cells were switched to 321C at the same time and were harvested at different times as indicated. Cells were lysed in Ultraspec RNA lysis solution (Biotecxs Laboratory, Houston, TX, USA), and total cellular RNA was isolated according to the vendor's protocol. Approximately 15 mg of each total RNA was used in Northern blot analysis. The PRC1 mRNA was detected with a 340 bp 32 P-labeled cDNA probe corresponding to the region 558-897 of PRC1 cDNA sequence. The membrane was stripped and reprobed with a human GAPDH probe to ensure equal amount of loading. The hybridization signals were visualized by a BioRad PhosphoImager and were quantified by the program of Quantity One.
The PRC1 probe was generated by reverse transcription (RT)-PCR reaction followed by purification with DNA Clean & Concentrator TM -5 Kit (Zymo research, CA, USA). The total RNA isolated from MCF-7 cells was used in the RT reaction.
The sequences used in the RT-PCR of the probe and other experiments are listed in the table. The conditions for the PCR reactions were as follows: 941C 1.5 min followed by 941C 20 s, 601C 20 s, 721C 30 s for 30 cycles and a final extension at 721C for 5 min. PCR product was sequenced to ensure the correct sequence.
Selection of pBSp53-transfected cells
T47D and HeLa cells were cotransfected with pEGFP and pBSp53 or pBS empty vector by FuGENE 6 reagent (Roche). The ratio of pEGFP and pBSp53 or pBS is one to two. At 2 days after transfection, cells were removed from dishes by trypsin and resuspended in fresh medium. The pEGFPpositive cells were selected by flow cytometry (FACS Vantage SE, Becton Dickinson). Approximately 0.5 Â 10 6 cells were used for real-time PCR and the rest of the cells were cultured overnight for p53 immunostaining and DAPI staining.
Quantitation of PRC1 mRNA expression
To quantitatively measure PRC1 mRNA levels in MCF7-ptsp53 and MCF-7 cells cultured at 371C or 321C for different intervals as well as in selected pBSp53 or mock-transfected T47D, HeLa, HCT116 p53 À/À cells, and HCT116 p53 þ / þ cells treated with 5-FU or Dox, real-time PCR was conducted. Total RNA was isolated from different cell samples by RNAeasy kit (Qiagen). cDNAs were prepared by using Eppendorf kit (Brinkmann Instruments, Inc., NY, USA). Real-time PCR was performed on the cDNA using the ABI Prism 7900-HT Sequence Detection System and Universal MasterMix (Applied Biosystems). PRC1 and GAPDH mRNA expression levels were assessed using the human PRC1 and GAPDH Pre-Developed O Becon Gene Expression Set (Gorilla Genomics).
Western blot analysis
Cells were lysed with 1 Â cold lysis buffer containing a complete mini protease inhibitor cocktail (Roche Molecular Biochemicals) as previously described (Li et al., 2003) . Approximately 50 mg protein of total cell lysate was separated on 4-20% SDS-PAGE, and transferred to nitrocellulose membranes. The membranes were blotted with the rabbit anti-PRC1 serum used at a 1 : 10000 dilution, and the signals were detected with an enhanced chemiluminescence (ECL) detection system (Amersham). Membranes were stripped and reblotted with anti-a-actin antibody (Chemicon) to ensure equal amount of protein loading. The signals were quantitated with a BioRad Fluo-S Multi Imager System.
Detection of binucleated cells by p53 immunostaining and DAPI staining
The MCF7-ptsp53 and MCF-7 cells at 371C or 321C for 2 days, as well as selected pBSp53-or pBS-transfected HCT116 p53 À/À , HeLa, and T47D cells were cultured on coverslips. The cells were washed with ice-cold PBS and fixed in cold methanol (À201C) for 10 min. After two washes with PBS, cells were incubated for 1 h in blocking buffer (0.4% Triton X-100, 0.1% gelatin, 1% BSA in PBS). For MCF7-ptsp53 or MCF-7 cells, anti-p53 antibody Pab246 (Santa Cruz) was used, for all other cell lines, anti-p53 antibody DO-1 (Santa Cruz) was used. The cells were incubated with the primary antibodies at 2 mg/ml for 1 h at room temperature. After washing with PBS, the cells were incubated with FITC-conjugated secondary antibody (1 : 200 dilution) for 1 h at room temperature. After two washes with PBS, cells were stained with DAPI at a concentration of 1 mg/ml. After rinsing with PBS and drying the coverslips, the coverslips were mounted in an antifading reagent (Molecular Probes, OR, USA). Images were recorded by a Penguin 600CL digital camera connected to an inverted fluorescent microscope.
Cloning of the 5'-flanking region and portion of exon 1 of the human PRC1 gene Human genomic clone RPCI-11 was obtained from the Bacpac Resources (Children's Hospital Oakland Research Institute, Oakland, CA, USA). Using the genomic clone RPCI-11 as the template, a PCR reaction was performed to amply a 3030 bp fragment containing the 5 0 -flanking region and portion of exon 1 (À2964 to þ 76 relative to the transcription starting site). The resulting DNA fragment was first subcloned into the pCR2.1-TOPO vector using TOPO TA cloning kit (Invitrogen) and then was released by cutting with KpnI and XhoI. The 3 kb fragment was then inserted into a luciferase vector pGL3-basic at the Kpn1 and Xho1 sites. The resulting vector was named PRC1-3 kb. The correct orientation of the PRC1 promoter was verified by enzymatic mapping. Note that the portion of exon 1 does not include the ATG translation start codon to guarantee the correct translation of luciferase gene product.
Generation of PRC1 promoter deletion reporter constructs
To construct a series of PRC1 promoter luciferase reporters with different 5 0 deletions, site-directed mutagenesis was conducted on the template DNA PRC1-3 kb by using the QuickChangeTM Site-directed Mutagenesis Kit (Strategen, San Diego, CA, USA) to introduce a unique Kpn1 site at different locations within the PRC1 promoter sequence. The 5 0 region (from À2964 to different unique Kpn1 site) was released by cutting with Kpn1. The remaining fragment was religated by Takara ligation kit (Takara shuzo co., LTD., Japan).
To construct PRC1-281-del, site-directed mutagenesis was conducted on the template DNA PRC1-281 to introduce a unique Mlu1 site at À216. By using the resulting plasmid as template, another Mlu1 site at -163 was created. The region from -216 to -163 was released by cutting with Mlu1, the remaining fragment was religated by Takara ligation kit.
The PRC1-281-mu-GC2 and mu-NFkB were conducted by site-directed mutagenesis to mutate the core region of the transcription factor-binding site. The altered sequences were scanned by TRANSFAC software to ensure no new transcription-binding sites being created.
Transfection assay
Cells were seeded in 24-well plates and incubated for 24 h in RPMI-1640 medium containing 10% FBS before transfection. A total of 200 ng DNA/well was transfected into cells using FuGENE 6 transfection reagent (Roche, # 1814443). The DNA ratios of the analysing firefly luciferase reporter to expression vector and to renilla luciferase reporter, pRSV-Luc, were 65 : 25 : 10. Transfected cells were incubated for 48 h prior to cell lysis. Luciferase activities were measured using the Promega Dual Luciferase Assay System.
ChIP assays
Experiments were performed with the ChIP kit (Upstate Biotechnology, Lake Placid, NY, USA) according to the manufacturer's instructions. Briefly, MCF7-ptsp53 or MCF-7 cells cultured at 371C or 321C for 2 days were crosslinked with 0.37% formaldehyde and the genomic DNA was sheared by sonication. The samples were then immunoprecipated with antibody against p53 (FL-393, Santa Cruz). Normal rabbit IgG (Santa Cruz) was used as a negative control. The immunocomplex was heated at 651C for 4 h to revert the crosslinking between DNA and proteins. The purified bound DNA was dissolved in 20 ml of Tris buffer (10 mM Tris, pH 8.5). The input DNA was diluted 100 Â prior to PCR. The bound and the input DNA were analysed by PCR (32 cycles) with primers that amplify a 357 bp fragment of the human PRC1 proximal promoter region from À281 to þ 76, relative to the major 
GCCGCCACTCCGGCGCTaCgCgtGCCCTGCTCGCGAGTC
PRC1 ChIP primers
Sense strand CTTGAGGCTGCCGCCAAGCCAG Antisense strand CGGACGCTCCAAGCAGCCGTGAG P21 ChIP primers Sense strand GTGGCTCTGATTGGCTTTCTG Antisense strand CTGAAAACAGGCAGCCCAAG
The generated Kpn1 or Mlu site is lower case and bold. The mutated nucleotides are lower case, bold, and italic
Regulation of PRC1 by p53 C Li et al transcription start site. The PCR conditions were 951C for 1.5 min, 951C for 20 s, 651C for 20 s, 721C for 40 s, and 721C for 5 min. As a positive control, the primers that amplify the p21 promoter fragment were used for PCR (Kaeser and Iggo, 2002) . The sequences of the primers were presented in Table 1 . The PCR products were visualized on a 2% agarose gel stained with ethidium bromide. The intensity of the PCR products was scanned with a BioRad Fluro-S MultiImager System and quantified by the Quantity One Program. Different amounts of template DNA were tested in the PCR reaction to ensure a linear range of DNA amplification.
Abbreviations bp, base-pair; 5-FU, 5 0 -fluorouracil; Dox, doxorubicin; GFP, green fluorescent protein; PRC1, protein regulator of cytokinesis; siRNA, small interfering RNA; TS, temperature sensitive; wt, wild type.
